跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,162 条关于
“complement factor C5a”
全部
16,162
临床试验
10,887
药物
1,229
机构
47
资讯
3,999
3年前
FDA Grants Emergency Use Authorization for Vilobelimab in Treating Critically Ill COVID-19 Patients
去年
InflaRx Receives EMA Recommendation for Vilobelimab in COVID-19 Treatment
2年前
InflaRx's GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial
去年
InflaRx's Vilobelimab Receives Positive CHMP Opinion for SARS-CoV-2-Induced ARDS
去年
InflaRx's Vilobelimab Receives Positive CHMP Opinion for COVID-19-Induced ARDS
10个月前
InflaRx to Report Phase 2a Results for Oral C5aR Inhibitor INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
去年
InflaRx's Vilobelimab Receives Positive CHMP Opinion for COVID-19-Induced ARDS
去年
InflaRx's Gohibic (vilobelimab) Receives European Commission Approval for SARS-CoV-2-Induced ARDS
8个月前
InflaRx Reports Encouraging Post-Hoc Analyses for Vilobelimab in Pyoderma Gangrenosum Despite Phase 3 Trial Termination
去年
24+ Companies Advancing Hidradenitis Suppurativa Treatment Pipeline with Novel Therapies
第 1 页,共 400 页
上一页
下一页